Oncolytic adenoviral vectors and methods and uses related thereto

Details for Australian Patent Application No. 2009332883 (hide)

Owner Oncos Therapeutics Oy

Inventors Hemminki, Akseli; Kanerva, Anna; Cerullo, Vincenzo; Pesonen, Sari

Agent Griffith Hack

Pub. Number AU-A-2009332883

PCT Pub. Number WO2010/072900

Priority 12/585,971 29.09.09 US; 20095466 27.04.09 FI; 20080671 22.12.08 FI

Filing date 21 December 2009

Wipo publication date 1 July 2010

International Classifications

C07K 14/535 (2006.01) Peptides having more than 20 amino acids

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/072900 Priority application(s): WO2010/072900

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009332887-Nucleic acid purification method

2009332877-Method and arrangement for removing solid particles and tar component from carbon monoxide gas